4Sernyak M J, Leslie DL, Alarcon RD, et al. Association of diabetes mellitus with use of atypical neuroleptic in the treatment of schizophrenia. Am J Psychiatry, 2002,159 (4): 561-566. 被引量：1
5H agg S, Joelsson L, Mj Ondal T, et al. Prevalence of diabetes and impaired glucosetolerance in patients with conventional depot neuroleptic medications. J Clin Psychiatry, 1998, 59 (6): 294-29. 被引量：1
6Atmaca M, kuloglu M, Tezcan E, et al. Serum leptin and triglcerffe levels in patients on treatment with atypical antipsycchotics. J Clin Psychiatry, 2003; 64 (5): 598-604. 被引量：1
7Heiskanen T, Niskanen L, Lyytik R, et al. Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry, 2003,64 (5): 575-579. 被引量：1
8Atmaca M, Kuloglu M, Tezcan E, et al. Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts. Acta Psychiatr Scan. 2003,108: 208-214. 被引量：1
9Zhang Y, Proenca R, Maffei M, et al. Positional Cloning of the mouse obese gene and its human homologue. Nature, 1994, 372: 425-432. 被引量：1
10Halaas JL, Gajiwala KS, Mallei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene.Science, 1995; 269: 543-6. 被引量：1
10Simpson GM, Glick ID, Weiden PJ, et al. Randomized, controlled, double-blind multicenter comparison of efficacy and tolerability of ziprasi done and olanzapine in acutely Ⅲ inpatients with schizo- phrenia and schizoaffective disorder [ J ]. Am J Psychiatry, 2004, 161 : 1837-1847. 被引量：1
